Stockholders' Deficit (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
|
|
|
Aug. 31, 2020 |
Jun. 30, 2020 |
Jun. 16, 2020 |
May 27, 2020 |
May 05, 2020 |
May 04, 2020 |
Dec. 23, 2019 |
May 12, 2019 |
Mar. 27, 2019 |
Aug. 31, 2020 |
Sep. 30, 2017 |
Sep. 30, 2020 |
Jun. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Jun. 09, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Common stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
10,000,000,000
|
|
|
10,000,000,000
|
|
|
10,000,000,000
|
|
Common stock par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
Preferred stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
5,000,000
|
|
|
|
|
Preferred stock par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
|
|
Number of common stock issued, value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,500
|
|
|
|
|
|
|
Gain on extinguishment of debt |
|
|
|
|
|
|
|
|
|
|
|
$ 389,864
|
|
|
$ 389,864
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
|
|
|
|
|
$ 59,800,000
|
|
|
$ 59,800,000
|
123,900,000
|
|
|
|
Debt converted into shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
589,500
|
|
|
|
|
Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
1,866,929
|
|
|
1,866,929
|
|
|
964,894
|
|
Common stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
1,866,929
|
|
|
1,866,929
|
|
|
964,894
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,950
|
|
|
|
Interest expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,500,000
|
|
|
|
Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
335,400,000
|
|
|
335,400,000
|
|
|
|
|
Warrant expiration date |
|
|
|
|
|
|
|
Mar. 31, 2022
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
|
$ 5,400,000
|
$ 4,100,000
|
|
|
|
|
|
|
|
|
|
|
Interest expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,500,000
|
|
|
|
2007 Equity Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,950
|
|
|
|
Weighted average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years 7 months 6 days
|
|
|
|
|
Intrinsic value of options exercisable |
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
$ 0
|
|
|
|
|
Alcimede LLC [Member] | Mr. Lagan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Voting rights percentage |
|
|
|
Mr. Lagan and Alcimede LLC, the holders of 50.25% of the total voting power of the Company's voting securities.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reverse stock split, description |
|
|
|
1-for-100 to 1-for-10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued upon conversion, value |
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange and Redemption Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on extinguishment of debt |
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
|
|
400,000
|
|
|
|
|
Interest expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,300,000
|
|
|
|
|
Series H Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
14,202
|
|
|
14,202
|
|
|
14,202
|
|
Preferred stock par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
Preferred stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
10
|
|
|
10
|
|
|
10
|
|
Preferred stock, stated value |
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
$ 1,000
|
|
|
|
|
Series F Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
1,750,000
|
|
|
1,750,000
|
|
|
|
|
Series F Convertible Preferred Stock [Member] | Genomas, Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common shares issued |
|
|
|
|
|
|
|
|
|
|
1,750,000
|
|
|
|
|
|
|
|
|
Number of common stock issued, value |
|
|
|
|
|
|
|
|
|
|
$ 174,097
|
|
|
|
|
|
|
|
|
Series L Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
250,000
|
|
|
|
|
Series M Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
30,000
|
|
30,000
|
30,000
|
|
Preferred stock par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
$ 1,000
|
$ 0.01
|
|
Preferred stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
22,000
|
|
|
22,000
|
|
|
0
|
|
Debt and accrued interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 22,000,000
|
|
|
|
|
Debt description |
|
|
Regardless of the number of shares of Series M Preferred Stock outstanding and so long as at least one share of Series M Preferred Stock is outstanding, the outstanding shares of Series M Preferred Stock shall have the number of votes, in the aggregate, equal to 51% of all votes entitled to be voted at any meeting of stockholders or action by written consent. Each outstanding share of the Series M Preferred Stock shall represent its proportionate share of the 51% allocated to the outstanding shares of Series M Preferred Stock in the aggregate.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion rate |
|
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend rate |
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series M Preferred Stock [Member] | Mr. Diamantis [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, stated value |
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
Gain on extinguishment of debt |
|
$ 18,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange of shares |
|
22,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
|
|
|
|
|
$ 3,200,000
|
|
|
3,200,000
|
|
|
|
|
Debt and accrued interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18,800,000
|
|
|
|
|
Series N Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares authorized |
50,000
|
|
|
|
|
|
|
|
|
50,000
|
|
50,000
|
|
|
50,000
|
|
|
|
50,000
|
Preferred stock par value |
$ 1,000
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
|
$ 0.01
|
Preferred stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
30,304
|
|
|
30,304
|
|
|
|
0
|
Dividend rate |
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt conversion description |
The conversion price is equal to 90% of the lowest VWAP during the 10 trading days immediately prior to the conversion date. Holders of the Series N Preferred Stock are prohibited from converting Series N Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% (or, upon election of the holder, 9.99%) of the total number of shares of common stock then issued and outstanding. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after notice to the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt converted into shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
131
|
|
|
|
|
Series N Preferred Stock [Member] | Exchange and Redemption Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock issued, value |
|
|
|
|
|
|
|
|
|
$ 24,200,000
|
|
|
|
|
|
|
|
|
|
Series H Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock price percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85.00%
|
|
|
|
|
Series K Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
250,000
|
|
|
250,000
|
|
Preferred stock par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
Preferred stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
0
|
|
|
250,000
|
|
Series K Preferred Stock [Member] | Exchange Agreement [Member] | Alcimede LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued upon conversion, value |
|
|
|
|
$ 250,000
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative dividends percentage |
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
Series J Preferred Stock [Member] | Exchange Agreement [Member] | Alcimede LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued upon conversion, value |
|
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Series L Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
250,000
|
|
|
250,000
|
|
Preferred stock par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
$ 0.01
|
|
Preferred stock shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
250,000
|
|
|
0
|
|
Series L Preferred Stock [Member] | Exchange Agreement [Member] | Alcimede LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued upon conversion, value |
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series I-1 and Series I-2 Preferred Stock [Member] | Exchange and Redemption Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares authorized |
30,435.52
|
|
|
|
|
|
|
|
|
30,435.52
|
|
|
|
|
|
|
|
|
|
Number of common stock issued, value |
|
|
|
|
|
|
|
|
|
$ 6,257,616
|
|
|
|
|
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,700,000
|
|
|
|
|
Series I-2 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock shares outstanding |
30,435.52
|
|
|
|
|
|
|
|
|
30,435.52
|
|
|
|
|
|
|
|
|
|
Number of common shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
313,000
|
|
|
|
|
Number of shares converted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
236.30
|
982.101
|
|
|
|